ciglitazone has been researched along with Invasiveness, Neoplasm in 6 studies
ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Finally, the effect of 15d-PGJ2 on pancreatic cancer cell invasiveness and matrix metalloproteinase expression was determined." | 1.31 | Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells. ( Ethridge, RT; Evers, BM; Hashimoto, K, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Papi, A | 2 |
| Rocchi, P | 2 |
| Ferreri, AM | 2 |
| Guerra, F | 1 |
| Orlandi, M | 2 |
| Han, JS | 1 |
| Crowe, DL | 1 |
| Hashimoto, K | 1 |
| Ethridge, RT | 1 |
| Evers, BM | 1 |
| Sawai, H | 1 |
| Liu, J | 1 |
| Reber, HA | 1 |
| Hines, OJ | 1 |
| Eibl, G | 1 |
| Kim, KH | 1 |
| Cho, YS | 1 |
| Park, JM | 1 |
| Yoon, SO | 1 |
| Kim, KW | 1 |
| Chung, AS | 1 |
6 other studies available for ciglitazone and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Enhanced effects of PPARgamma ligands and RXR selective retinoids in combination to inhibit migration and invasiveness in cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Drug Synergism; Humans; Matrix Metalloprotei | 2009 |
RXRgamma and PPARgamma ligands in combination to inhibit proliferation and invasiveness in colon cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Movement; Cell Proliferation; Cell S | 2010 |
Steroid receptor coactivator 1 deficiency increases MMTV-neu mediated tumor latency and differentiation specific gene expression, decreases metastasis, and inhibits response to PPAR ligands.
Topics: Animals; Antineoplastic Agents; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Chromati | 2010 |
Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.
Topics: 3T3 Cells; Adenocarcinoma; alpha Catenin; Animals; Antineoplastic Agents; Apoptosis; beta Catenin; C | 2002 |
Activation of peroxisome proliferator-activated receptor-gamma decreases pancreatic cancer cell invasion through modulation of the plasminogen activator system.
Topics: Cell Line, Tumor; Down-Regulation; Humans; Ligands; Neoplasm Invasiveness; Pancreatic Neoplasms; Pla | 2006 |
Pro-MMP-2 activation by the PPARgamma agonist, ciglitazone, induces cell invasion through the generation of ROS and the activation of ERK.
Topics: Enzyme Activation; Enzyme Precursors; Extracellular Signal-Regulated MAP Kinases; Fibrosarcoma; Gela | 2007 |